 |
PDBsum entry 1kxr
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
108:649-660
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Ca(2+) switch aligns the active site of calpain.
|
|
T.Moldoveanu,
C.M.Hosfield,
D.Lim,
J.S.Elce,
Z.Jia,
P.L.Davies.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Ca(2+) signaling by calpains leads to controlled proteolysis during processes
ranging from cytoskeleton remodeling in mammals to sex determination in
nematodes. Deregulated Ca(2+) levels result in aberrant proteolysis by calpains,
which contributes to tissue damage in heart and brain ischemias as well as
neurodegeneration in Alzheimer's disease. Here we show that activation of the
protease core of mu calpain requires cooperative binding of two Ca(2+) atoms at
two non-EF-hand sites revealed in the 2.1 A crystal structure. Conservation of
the Ca(2+) binding residues defines an ancestral general mechanism of activation
for most calpain isoforms, including some that lack EF-hand domains. The
protease region is not affected by the endogenous inhibitor, calpastatin, and
may contribute to calpain-mediated pathologies when the core is released by
autoproteolysis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Ca^2+-Induced Conformational Changes in the
Active Site Region of Calpain and Proposed Activation
Mechanism(A) DI and II of inactive human m calpain (Strobl et
al., 2000). The ribbon presentation is colored pink, with the
side chains of three critical residues (equivalent to μ R104,
W298, and E333) colored orange. DI and II are rotated 5°
relative to each other, and C105 and H262 are 10.5 Å
apart.(B) DI of μI-II (blue) was overlapped onto DI from m
calpain (pink) using the program Align (Cohen, 1997). The gold
sphere indicates the Ca^2+ ion.(C) Exposure of the Ca^2+ binding
site in DII (cyan) resulting from attraction of the E333 side
chain by R104 from DI.(D) R104-E333 double salt bridge stereo
view.(E) Overlap of DII from μI-II (cyan) onto DII from m
calpain (pink) showing the loops that coordinate the second
Ca^2+. Note: a discrepancy in the m calpain structure around
G295 results in a discontinuity in that peptide loop.(F) Stereo
view of the hydrophobic pocket formed by Ca^2+ binding to
DII.(G) Ca^2+ bound μI-II, showing the arrangement of the Ca^2+
ions relative to the active site cleft. This is a 90°
rotation of the view in Figure 2A.
|
 |
Figure 6.
Figure 6. Regulation of Heterodimeric Calpain by Ca^2+A
generic model for Ca^2+ bound calpain was constructed by
substituting the Ca^2+ bound structure of DI-II into the human m
calpain heterodimer (Strobl et al., 2000) while overlapping DIV
and VI with the Ca^2+ bound DVI heterodimer structure (Blanchard
et al., 1997). DII was positioned to optimize DIII interactions.
The anchor peptide (red helix) was placed in the Ca^2+-free
conformation where it interacts with DVI (gray). Two consecutive
yet cooperative levels of Ca^2+ regulation are proposed, both
acting on a different segment of the circularized structure.
Stage 1 includes anchor release (Nakagawa et al., 2001), shown
by the red dotted arrow. As well, under certain conditions small
subunit dissociation (Pal et al., 2001) and the potential
binding of Ca^2+ to DIII (Hosfield et al. 2001 and Tompa et al.
2001) may help free the protease region from constraints. Stage
2 is active site assembly (black dotted arrows) as seen in
μI-II. It follows the onset of stage 1 but may also influence
it if the tendency to realign the active site pulls against the
restraint. Ca^2+ ions are colored gold (seen in X-ray
structures) or red (postulated or confirmed by mutagenesis; Dutt
et al., 2000). Transparent spheres in DIV and VI are Ca^2+ at
EF-4 sites that are likely filled only at high CaCl[2] (>20 mM)
concentrations. Calpain association with membranes (double gray
lines) may also contribute to activation (as reviewed in
Nakagawa et al., 2001).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2002,
108,
649-660)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.O.Donkor
(2011).
Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.
|
| |
Expert Opin Ther Pat,
21,
601-636.
|
 |
|
|
|
|
 |
K.Sato,
S.Minegishi,
J.Takano,
F.Plattner,
T.Saito,
A.Asada,
H.Kawahara,
N.Iwata,
T.C.Saido,
and
S.Hisanaga
(2011).
Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
|
| |
J Neurochem,
117,
504-515.
|
 |
|
|
|
|
 |
D.A.Boudreaux,
T.K.Maiti,
C.W.Davies,
and
C.Das
(2010).
Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.
|
| |
Proc Natl Acad Sci U S A,
107,
9117-9122.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Sorimachi,
S.Hata,
and
Y.Ono
(2010).
Expanding members and roles of the calpain superfamily and their genetically modified animals.
|
| |
Exp Anim,
59,
549-566.
|
 |
|
|
|
|
 |
J.S.Gilchrist,
T.Cook,
B.Abrenica,
B.Rashidkhani,
and
G.N.Pierce
(2010).
Extensive autolytic fragmentation of membranous versus cytosolic calpain following myocardial ischemia-reperfusion.
|
| |
Can J Physiol Pharmacol,
88,
584-594.
|
 |
|
|
|
|
 |
R.Rolius,
C.Antoniou,
L.A.Nazarova,
S.H.Kim,
G.Cobb,
P.Gala,
P.Rajaram,
Q.Li,
and
L.W.Fung
(2010).
Inhibition of calpain but not caspase activity by spectrin fragments.
|
| |
Cell Mol Biol Lett,
15,
395-405.
|
 |
|
|
|
|
 |
S.G.Gornik,
G.D.Westrop,
G.H.Coombs,
and
D.M.Neil
(2010).
Molecular cloning and localization of a calpain-like protease from the abdominal muscle of Norway lobster Nephrops norvegicus.
|
| |
Mol Biol Rep,
37,
2009-2019.
|
 |
|
|
|
|
 |
W.J.Chang,
M.Chehab,
S.Kink,
and
L.H.Toledo-Pereyra
(2010).
Intracellular calcium signaling pathways during liver ischemia and reperfusion.
|
| |
J Invest Surg,
23,
228-238.
|
 |
|
|
|
|
 |
A.Trümpler,
B.Schlott,
P.Herrlich,
P.A.Greer,
and
F.D.Böhmer
(2009).
Calpain-mediated degradation of reversibly oxidized protein-tyrosine phosphatase 1B.
|
| |
FEBS J,
276,
5622-5633.
|
 |
|
|
|
|
 |
I.O.Donkor,
H.Assefa,
and
J.Liu
(2008).
Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.
|
| |
J Med Chem,
51,
4346-4350.
|
 |
|
|
|
|
 |
J.Qian,
D.Cuerrier,
P.L.Davies,
Z.Li,
J.C.Powers,
and
R.L.Campbell
(2008).
Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
|
| |
J Med Chem,
51,
5264-5270.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.A.Bondareva,
and
N.N.Nemova
(2008).
[Molecular evolution of intracellular Ca2+-dependent proteases]
|
| |
Bioorg Khim,
34,
295-302.
|
 |
|
|
|
|
 |
R.A.Hanna,
R.L.Campbell,
and
P.L.Davies
(2008).
Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
|
| |
Nature,
456,
409-412.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Mellgren
(2008).
Structural biology: Enzyme knocked for a loop.
|
| |
Nature,
456,
337-338.
|
 |
|
|
|
|
 |
T.Moldoveanu,
K.Gehring,
and
D.R.Green
(2008).
Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
|
| |
Nature,
456,
404-408.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Fernández-Montalván,
T.Bouwmeester,
G.Joberty,
R.Mader,
M.Mahnke,
B.Pierrat,
J.M.Schlaeppi,
S.Worpenberg,
and
B.Gerhartz
(2007).
Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.
|
| |
FEBS J,
274,
4256-4270.
|
 |
|
|
|
|
 |
D.Cuerrier,
T.Moldoveanu,
R.L.Campbell,
J.Kelly,
B.Yoruk,
S.H.Verhelst,
D.Greenbaum,
M.Bogyo,
and
P.L.Davies
(2007).
Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
|
| |
J Biol Chem,
282,
9600-9611.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.E.Croall,
and
K.Ersfeld
(2007).
The calpains: modular designs and functional diversity.
|
| |
Genome Biol,
8,
218.
|
 |
|
|
|
|
 |
J.E.Kammenga,
A.Doroszuk,
J.A.Riksen,
E.Hazendonk,
L.Spiridon,
A.J.Petrescu,
M.Tijsterman,
R.H.Plasterk,
and
J.Bakker
(2007).
A Caenorhabditis elegans wild type defies the temperature-size rule owing to a single nucleotide polymorphism in tra-3.
|
| |
PLoS Genet,
3,
e34.
|
 |
|
|
|
|
 |
J.S.Evans,
and
M.D.Turner
(2007).
Emerging functions of the calpain superfamily of cysteine proteases in neuroendocrine secretory pathways.
|
| |
J Neurochem,
103,
849-859.
|
 |
|
|
|
|
 |
M.Averna,
R.Stifanese,
R.De Tullio,
M.Passalacqua,
E.Defranchi,
F.Salamino,
E.Melloni,
and
S.Pontremoli
(2007).
Regulation of calpain activity in rat brain with altered Ca2+ homeostasis.
|
| |
J Biol Chem,
282,
2656-2665.
|
 |
|
|
|
|
 |
S.Hata,
N.Doi,
F.Kitamura,
and
H.Sorimachi
(2007).
Stomach-specific calpain, nCL-2/calpain 8, is active without calpain regulatory subunit and oligomerizes through C2-like domains.
|
| |
J Biol Chem,
282,
27847-27856.
|
 |
|
|
|
|
 |
A.Fernández-Montalván,
I.Assfalg-Machleidt,
D.Pfeiler,
H.Fritz,
M.Jochum,
and
W.Machleidt
(2006).
Mu-calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation.
|
| |
Biol Chem,
387,
617-627.
|
 |
|
|
|
|
 |
C.Frangié,
W.Zhang,
J.Perez,
Y.C.Dubois,
J.P.Haymann,
and
L.Baud
(2006).
Extracellular calpains increase tubular epithelial cell mobility. Implications for kidney repair after ischemia.
|
| |
J Biol Chem,
281,
26624-26632.
|
 |
|
|
|
|
 |
E.Melloni,
M.Averna,
R.Stifanese,
R.De Tullio,
E.Defranchi,
F.Salamino,
and
S.Pontremoli
(2006).
Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?
|
| |
J Biol Chem,
281,
24945-24954.
|
 |
|
|
|
|
 |
F.Salamino,
R.Minafra,
V.Grano,
N.Diano,
D.G.Mita,
S.Pontremoli,
and
E.Melloni
(2006).
Effect of extremely low frequency magnetic fields on calpain activation.
|
| |
Bioelectromagnetics,
27,
43-50.
|
 |
|
|
|
|
 |
H.Shao,
J.Chou,
C.J.Baty,
N.A.Burke,
S.C.Watkins,
D.B.Stolz,
and
A.Wells
(2006).
Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.
|
| |
Mol Cell Biol,
26,
5481-5496.
|
 |
|
|
|
|
 |
J.Joy,
N.Nalabothula,
M.Ghosh,
O.Popp,
M.Jochum,
W.Machleidt,
S.Gil-Parrado,
and
T.A.Holak
(2006).
Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d).
|
| |
Biol Chem,
387,
329-335.
|
 |
|
|
|
|
 |
J.L.Hood,
W.H.Brooks,
and
T.L.Roszman
(2006).
Subcellular mobility of the calpain/calpastatin network: an organelle transient.
|
| |
Bioessays,
28,
850-859.
|
 |
|
|
|
|
 |
M.Averna,
R.Stifanese,
R.De Tullio,
E.Defranchi,
F.Salamino,
E.Melloni,
and
S.Pontremoli
(2006).
Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
|
| |
FEBS J,
273,
1660-1668.
|
 |
|
|
|
|
 |
M.E.Saez,
R.Ramirez-Lorca,
F.J.Moron,
and
A.Ruiz
(2006).
The therapeutic potential of the calpain family: new aspects.
|
| |
Drug Discov Today,
11,
917-923.
|
 |
|
|
|
|
 |
M.T.Naik,
N.Suree,
U.Ilangovan,
C.K.Liew,
W.Thieu,
D.O.Campbell,
J.J.Clemens,
M.E.Jung,
and
R.T.Clubb
(2006).
Staphylococcus aureus Sortase A transpeptidase. Calcium promotes sorting signal binding by altering the mobility and structure of an active site loop.
|
| |
J Biol Chem,
281,
1817-1826.
|
 |
|
|
|
|
 |
S.Duguez,
M.Bartoli,
and
I.Richard
(2006).
Calpain 3: a key regulator of the sarcomere?
|
| |
FEBS J,
273,
3427-3436.
|
 |
|
|
|
|
 |
S.Hata,
S.Koyama,
H.Kawahara,
N.Doi,
T.Maeda,
N.Toyama-Sorimachi,
K.Abe,
K.Suzuki,
and
H.Sorimachi
(2006).
Stomach-specific calpain, nCL-2, localizes in mucus cells and proteolyzes the beta-subunit of coatomer complex, beta-COP.
|
| |
J Biol Chem,
281,
11214-11224.
|
 |
|
|
|
|
 |
D.Cuerrier,
T.Moldoveanu,
and
P.L.Davies
(2005).
Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions.
|
| |
J Biol Chem,
280,
40632-40641.
|
 |
|
|
|
|
 |
G.Nicastro,
R.P.Menon,
L.Masino,
P.P.Knowles,
N.Q.McDonald,
and
A.Pastore
(2005).
The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.
|
| |
Proc Natl Acad Sci U S A,
102,
10493-10498.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Ersfeld,
H.Barraclough,
and
K.Gull
(2005).
Evolutionary relationships and protein domain architecture in an expanded calpain superfamily in kinetoplastid parasites.
|
| |
J Mol Evol,
61,
742-757.
|
 |
|
|
|
|
 |
L.Satish,
H.C.Blair,
A.Glading,
and
A.Wells
(2005).
Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.
|
| |
Mol Cell Biol,
25,
1922-1941.
|
 |
|
|
|
|
 |
M.Bartoli,
and
I.Richard
(2005).
Calpains in muscle wasting.
|
| |
Int J Biochem Cell Biol,
37,
2115-2133.
|
 |
|
|
|
|
 |
M.D.Turner,
P.G.Cassell,
and
G.A.Hitman
(2005).
Calpain-10: from genome search to function.
|
| |
Diabetes Metab Res Rev,
21,
505-514.
|
 |
|
|
|
|
 |
M.Ghosh,
S.Shanker,
I.Siwanowicz,
K.Mann,
W.Machleidt,
and
T.A.Holak
(2005).
Proteolysis of insulin-like growth factor binding proteins (IGFBPs) by calpain.
|
| |
Biol Chem,
386,
85-93.
|
 |
|
|
|
|
 |
M.Ridderstråle,
H.Parikh,
and
L.Groop
(2005).
Calpain 10 and type 2 diabetes: are we getting closer to an explanation?
|
| |
Curr Opin Clin Nutr Metab Care,
8,
361-366.
|
 |
|
|
|
|
 |
P.Friedrich,
and
Z.Bozóky
(2005).
Digestive versus regulatory proteases: on calpain action in vivo.
|
| |
Biol Chem,
386,
609-612.
|
 |
|
|
|
|
 |
R.Benetti,
T.Copetti,
S.Dell'Orso,
E.Melloni,
C.Brancolini,
M.Monte,
and
C.Schneider
(2005).
The calpain system is involved in the constitutive regulation of beta-catenin signaling functions.
|
| |
J Biol Chem,
280,
22070-22080.
|
 |
|
|
|
|
 |
Z.Z.Chong,
F.Li,
and
K.Maiese
(2005).
Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.
|
| |
Brain Res Brain Res Rev,
49,
1.
|
 |
|
|
|
|
 |
Z.Z.Chong,
F.Li,
and
K.Maiese
(2005).
Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.
|
| |
Prog Neurobiol,
75,
207-246.
|
 |
|
|
|
|
 |
A.Alexa,
Z.Bozóky,
A.Farkas,
P.Tompa,
and
P.Friedrich
(2004).
Contribution of distinct structural elements to activation of calpain by Ca2+ ions.
|
| |
J Biol Chem,
279,
20118-20126.
|
 |
|
|
|
|
 |
A.Glading,
R.J.Bodnar,
I.J.Reynolds,
H.Shiraha,
L.Satish,
D.A.Potter,
H.C.Blair,
and
A.Wells
(2004).
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation.
|
| |
Mol Cell Biol,
24,
2499-2512.
|
 |
|
|
|
|
 |
B.G.Diaz,
T.Moldoveanu,
M.J.Kuiper,
R.L.Campbell,
and
P.L.Davies
(2004).
Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide.
|
| |
J Biol Chem,
279,
27656-27666.
|
 |
|
|
|
|
 |
D.Reverter,
and
C.D.Lima
(2004).
A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex.
|
| |
Structure,
12,
1519-1531.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Carafoli
(2004).
Calcium-mediated cellular signals: a story of failures.
|
| |
Trends Biochem Sci,
29,
371-379.
|
 |
|
|
|
|
 |
K.H.Wu,
and
P.C.Tai
(2004).
Cys32 and His105 are the critical residues for the calcium-dependent cysteine proteolytic activity of CvaB, an ATP-binding cassette transporter.
|
| |
J Biol Chem,
279,
901-909.
|
 |
|
|
|
|
 |
P.Friedrich,
P.Tompa,
and
A.Farkas
(2004).
The calpain-system of Drosophila melanogaster: coming of age.
|
| |
Bioessays,
26,
1088-1096.
|
 |
|
|
|
|
 |
T.Moldoveanu,
Z.Jia,
and
P.L.Davies
(2004).
Calpain activation by cooperative Ca2+ binding at two non-EF-hand sites.
|
| |
J Biol Chem,
279,
6106-6114.
|
 |
|
|
|
|
 |
Veeranna,
T.Kaji,
B.Boland,
T.Odrljin,
P.Mohan,
B.S.Basavarajappa,
C.Peterhoff,
A.Cataldo,
A.Rudnicki,
N.Amin,
B.S.Li,
H.C.Pant,
B.L.Hungund,
O.Arancio,
and
R.A.Nixon
(2004).
Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.
|
| |
Am J Pathol,
165,
795-805.
|
 |
|
|
|
|
 |
E.Carafoli,
and
S.Ringer
(2003).
The calcium-signalling saga: tap water and protein crystals.
|
| |
Nat Rev Mol Cell Biol,
4,
326-332.
|
 |
|
|
|
|
 |
E.Kimura,
K.Abe,
K.Suzuki,
and
H.Sorimachi
(2003).
Heterogeneous nuclear ribonucleoprotein K interacts with and is proteolyzed by calpain in vivo.
|
| |
Biosci Biotechnol Biochem,
67,
1786-1796.
|
 |
|
|
|
|
 |
F.Raynaud,
C.Bonnal,
E.Fernandez,
L.Bremaud,
M.Cerutti,
M.C.Lebart,
C.Roustan,
A.Ouali,
and
Y.Benyamin
(2003).
The calpain 1-alpha-actinin interaction. Resting complex between the calcium-dependent protease and its target in cytoskeleton.
|
| |
Eur J Biochem,
270,
4662-4670.
|
 |
|
|
|
|
 |
G.P.Pal,
T.De Veyra,
J.S.Elce,
and
Z.Jia
(2003).
Crystal structure of a micro-like calpain reveals a partially activated conformation with low Ca2+ requirement.
|
| |
Structure,
11,
1521-1526.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.P.Pal,
T.DeVeyra,
J.S.Elce,
and
Z.Jia
(2003).
Purification, crystallization and preliminary X-ray analysis of a mu-like calpain.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
369-371.
|
 |
|
|
|
|
 |
H.Sorimachi,
and
Y.Kawabata
(2003).
[Calpain and pathology in view of structure-function relationships]
|
| |
Nippon Yakurigaku Zasshi,
122,
21-29.
|
 |
|
|
|
|
 |
M.Taveau,
N.Bourg,
G.Sillon,
C.Roudaut,
M.Bartoli,
and
I.Richard
(2003).
Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components.
|
| |
Mol Cell Biol,
23,
9127-9135.
|
 |
|
|
|
|
 |
R.A.Nixon
(2003).
The calpains in aging and aging-related diseases.
|
| |
Ageing Res Rev,
2,
407-418.
|
 |
|
|
|
|
 |
R.Betts,
S.Weinsheimer,
G.E.Blouse,
and
J.Anagli
(2003).
Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT.
|
| |
J Biol Chem,
278,
7800-7809.
|
 |
|
|
|
|
 |
S.Gil-Parrado,
I.Assfalg-Machleidt,
F.Fiorino,
D.Deluca,
D.Pfeiler,
N.Schaschke,
L.Moroder,
and
W.Machleidt
(2003).
Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
|
| |
Biol Chem,
384,
395-402.
|
 |
|
|
|
|
 |
S.Gil-Parrado,
O.Popp,
T.A.Knoch,
S.Zahler,
F.Bestvater,
M.Felgenträger,
A.Holloschi,
A.Fernández-Montalván,
E.A.Auerswald,
H.Fritz,
P.Fuentes-Prior,
W.Machleidt,
and
E.Spiess
(2003).
Subcellular localization and in vivo subunit interactions of ubiquitous mu-calpain.
|
| |
J Biol Chem,
278,
16336-16346.
|
 |
|
|
|
|
 |
T.Moldoveanu,
C.M.Hosfield,
D.Lim,
Z.Jia,
and
P.L.Davies
(2003).
Calpain silencing by a reversible intrinsic mechanism.
|
| |
Nat Struct Biol,
10,
371-378.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Iwasaki,
H.Sasaki,
A.Nakamura,
K.Kohama,
and
M.Tanokura
(2003).
Metal-free and Ca2+-bound structures of a multidomain EF-hand protein, CBP40, from the lower eukaryote Physarum polycephalum.
|
| |
Structure,
11,
75-85.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Khorchid,
and
M.Ikura
(2002).
How calpain is activated by calcium.
|
| |
Nat Struct Biol,
9,
239-241.
|
 |
|
|
|
|
 |
C.B.Klee,
and
A.R.Means
(2002).
Keeping up with calcium: conference on calcium-binding proteins and calcium function in health and disease.
|
| |
EMBO Rep,
3,
823-827.
|
 |
|
|
|
|
 |
E.Dainese,
R.Minafra,
A.Sabatucci,
P.Vachette,
E.Melloni,
and
I.Cozzani
(2002).
Conformational changes of calpain from human erythrocytes in the presence of Ca2+.
|
| |
J Biol Chem,
277,
40296-40301.
|
 |
|
|
|
|
 |
M.Hu,
P.Li,
M.Li,
W.Li,
T.Yao,
J.W.Wu,
W.Gu,
R.E.Cohen,
and
Y.Shi
(2002).
Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.
|
| |
Cell,
111,
1041-1054.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |